Tateshi Kataoka

Title: Tateshi Kataoka: Innovator in Liposome-Based Therapeutics

Introduction: Tateshi Kataoka, an inventive mind based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals through his innovative research and development. With a patent under his name, he stands out as a key figure in the advancement of drug delivery systems.

Latest Patents: Tateshi Kataoka holds a patent for N.sup.4 -Acylcytosine arabinoside compositions. This innovative preparation features a liposome made of lecithin that encapsulates a N.sup.4 -acylcytosine arabinoside with an aliphatic acyl group ranging from C.sub.6-18. This unique formulation has potential applications in improving therapeutic efficacy and targeting in pharmaceutical treatments.

Career Highlights: Kataoka is currently associated with Asahi Kasei Kogyo Kabushiki Kaisha, a prominent company known for its involvement in the chemical and pharmaceutical industries. His work emphasizes the integration of advanced technology in drug formulation, showcasing his commitment to enhancing patient care through scientific research.

Collaborations: Throughout his career, Tateshi Kataoka has collaborated with notable coworkers such as Yoshio Sakurai and Fujiko Oh-hashi. These partnerships reflect a collaborative spirit within the research community, enabling the exchange of ideas and accelerating innovation in drug delivery systems.

Conclusion: Tateshi Kataoka's contributions to pharmaceutical science, particularly through his patented N.sup.4 -acylcytosine arabinoside compositions, signify his role as a prominent inventor. His work at Asahi Kasei Kogyo Kabushiki Kaisha and collaborations with other researchers underscore the importance of teamwork in fostering innovation and improving therapeutic options for patients.